Description

NSE circular announcing listing of equity shares allotted under ESOP for 7 companies including CREDITACCESS GRAMEEN, GPIL, HDFCAMC, and others, effective July 28, 2025.

Summary

NSE has announced the listing of further equity shares for seven companies following Employee Stock Option Plan (ESOP) allotments. The shares will be admitted to trading on the Capital Market segment with effect from July 28, 2025. Companies include CREDITACCESS GRAMEEN LIMITED, Godawari Power And Ispat limited, HDFC Asset Management Company Limited, JB Chemicals & Pharmaceuticals Limited, Lodha Developers Limited, Mufin Green Finance Limited, and Yes Bank Limited.

Key Points

  • Seven companies’ ESOP shares to be listed on NSE Capital Market segment
  • Effective date: July 28, 2025
  • All shares are pari passu with existing equity shares
  • Market lot size is 1 for all listed securities
  • No lock-in restrictions applicable for any of the allotments
  • Total new shares range from 3,750 (CREDITACC) to 259,077 (JBCHEPHARM)

Regulatory Changes

No regulatory changes introduced. This is a routine notification under Regulation 3.1.1 and 2.5.5 of NSE Capital Market Trading Regulations Part A for admission of securities to dealings.

Compliance Requirements

  • Companies must ensure proper identification of securities using designated codes
  • Trading must be conducted in specified lot sizes (all set to 1 share)
  • Securities will be identified by their designated codes for system trading purposes

Important Dates

  • Effective Date: July 28, 2025 - Commencement of trading for all newly listed shares
  • Allotment Dates: Range from July 3, 2025 (CREDITACC) to July 23, 2025 (LODHA)

Impact Assessment

Market Impact: Moderate increase in floating stock for the seven companies. The additional shares represent dilution for existing shareholders but provide liquidity enhancement. JBCHEPHARM has the largest addition with 259,077 shares, while CREDITACC has the smallest with 3,750 shares.

Operational Impact: Standard listing process with no operational complexities. All shares have uniform lot size of 1 and no lock-in restrictions, facilitating smooth trading operations.

Investor Impact: ESOP beneficiaries can now trade their allotted shares freely. Existing shareholders may experience minor dilution effects depending on the proportion of new shares relative to existing share capital.

Impact Justification

Routine listing of ESOP shares for multiple companies with moderate market impact due to increased share count